LONGITUDINAL NATURAL HISTORY OF PATIENTS WITH TYPE I/II HEREDITARY ANGIOEDEMA: ICATIBANT OUTCOME SURVEY DATA

被引:0
|
作者
Maurer, M.
Caballero, T.
Aberer, W.
Zanichelli, A.
Bouillet, L.
Bygum, A.
Grumach, A.
Pommie, C.
Andresen, I.
Longhurst, H.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P164
引用
收藏
页码:S42 / S43
页数:2
相关论文
共 50 条
  • [41] Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study
    Caballero, Teresa
    Zanichelli, Andrea
    Aberer, Werner
    Maurer, Marcus
    Longhurst, Hilary J.
    Bouillet, Laurence
    Andresen, Irmgard
    CLINICAL AND TRANSLATIONAL ALLERGY, 2018, 8
  • [42] Type I and Type II Hereditary Angioedema: Clinical and Laboratory Findings in Iranian Patients
    Kargarsharif, Fatemeh
    Mehranmehr, Narges
    Fard, Sara Zahedi
    Fazlollahi, Mohammad Reza
    Ayazi, Maryam
    Mohammadzadeh, Iraj
    Nabavi, Mohammad
    Bemanian, Mohammad Hasan
    Fayezi, Abbas
    Movahedi, Masoud
    Heidarzadeh, Marzieh
    Kalantari, Najmoclin
    Arefimehr, Somaieh
    Saghafi, Shiva
    Pourpak, Zahra
    ARCHIVES OF IRANIAN MEDICINE, 2015, 18 (07) : 425 - 429
  • [43] Long-term effectiveness and safety of icatibant for the on-demand treatment of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey
    Maurer, M.
    Longhurst, H. J.
    Bouillet, L.
    Caballero, T.
    Grumach, A. S.
    Botha, J.
    Andresen, I
    Aberer, W.
    ALLERGY, 2020, 75 : 59 - 60
  • [44] The effect of body mass index on icatibant treatment outcomes in patients with hereditary angioedema with C1 inhibitor deficiency: findings from the Icatibant outcome survey
    Caballero, T.
    Zanichelli, A.
    Aberer, W.
    Maurer, M.
    Longhurst, H.
    Bouillet, L.
    Fabien, V
    Andresen, I
    ALLERGY, 2015, 70 : 252 - 252
  • [45] Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study
    Grumach, Anete S.
    Henriques, Marina T.
    Bardou, Maine L. D.
    Pontarolli, Daniele A.
    Botha, Jaco
    Correa, Mariangela
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2022, 97 (04) : 448 - 457
  • [46] Efficacy of Icatibant for Cutaneous and Abdominal Attacks of Type I and II Hereditary Angioedema: A Pooled Analysis of Three Phase III trials
    Malbran, A.
    Li, H. H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB218 - AB218
  • [47] Hereditary angioedema type I patients with anti-C1-INH antibodies can be effectively treated with icatibant
    Bouillet, L.
    Boccon-Gibod, I
    Ponard, D.
    Dumestre-Perard, C.
    Cesbron, J.
    Massot, C.
    ALLERGY, 2009, 64 : 116 - 117
  • [48] Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom
    Longhurst, Hilary J.
    Dempster, John
    Lorenzo, Lorena
    Buckland, Matthew
    Grigoriadou, Sofia
    Symons, Christine
    Bethune, Claire
    Fabien, Vincent
    Bangs, Catherine
    Garcez, Tomaz
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2018, 14
  • [49] Real-world outcomes in hereditary angioedema: first experience from the Icatibant Outcome Survey in the United Kingdom
    Hilary J. Longhurst
    John Dempster
    Lorena Lorenzo
    Matthew Buckland
    Sofia Grigoriadou
    Christine Symons
    Claire Bethune
    Vincent Fabien
    Catherine Bangs
    Tomaz Garcez
    Allergy, Asthma & Clinical Immunology, 14
  • [50] Real-world outcomes in hereditary angioedema: first experience from the icatibant outcome survey in the United Kingdom
    Longhurst, H.
    Dempster, J.
    Lorenzo, L.
    Buckland, M.
    Grigoriadou, S.
    Fabien, V.
    Bangs, C.
    Helbert, M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2015, 45 (02): : 499 - 499